Caribou Biosciences (CRBU) FCF Margin (2020 - 2026)
Caribou Biosciences (CRBU) reported FCF Margin of 1126.41% for Q1 2026, up 43925.0% year-over-year from N/an in Q1 2025, and down 115.33% on a QoQ basis from 523.12% in Q4 2025.
Caribou Biosciences (CRBU) has 7 years of FCF Margin data on file, last reported at 1126.41% in Q1 2026.
- Quarterly FCF Margin rose 43925.0% year-over-year to 1126.41% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 915.1% (up 47368.0% YoY) and the FY2025 annual result came in at 1006.89%, up 38348.0% from the prior year.
- FCF Margin declined to 1126.41% in Q1 2026 per CRBU's latest filing, from 523.12% in the prior quarter.
- Across five years, FCF Margin topped out at 104.64% in Q3 2023 and bottomed at 1726.1% in Q4 2024.
- The 5-year median for FCF Margin is 850.38% (2022), against an average of 947.45%.
- The widest annual swing landed in 2022, when FCF Margin sank 212976 bps; it then jumped 120298 bps in 2025.
- Tracing CRBU's FCF Margin over 5 years: stood at 584.24% in 2022, then retreated by 4 bps to 604.69% in 2023, then tumbled by 185 bps to 1726.1% in 2024, then soared by 70 bps to 523.12% in 2025, then plunged by 115 bps to 1126.41% in 2026.
- Per Business Quant, the three latest CRBU FCF Margin figures stand at 1126.41% (Q1 2026), 523.12% (Q4 2025), and 1151.05% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | -1,126.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,126.41% |
| Dec 31, 2025 | -523.12% |
| Sep 30, 2025 | -1,151.05% |
| Jun 30, 2025 | -1,109.97% |
| Mar 31, 2025 | -1,565.66% |
| Dec 31, 2024 | -1,726.10% |
| Sep 30, 2024 | -1,623.47% |
| Jun 30, 2024 | -929.27% |
| Mar 31, 2024 | -1,566.65% |
| Dec 31, 2023 | -604.69% |
| Sep 30, 2023 | -104.64% |
| Jun 30, 2023 | -480.83% |
| Mar 31, 2023 | -846.74% |
| Dec 31, 2022 | -584.24% |
| Sep 30, 2022 | -798.24% |
| Jun 30, 2022 | -515.24% |
| Mar 31, 2022 | -850.38% |
| Dec 31, 2021 | -862.60% |
| Sep 30, 2021 | -399.72% |
| Jun 30, 2021 | -1,149.05% |
| Mar 31, 2021 | 1,279.38% |
| Dec 31, 2020 | -823.48% |
| Sep 30, 2020 | -726.63% |